Cellectar Biosciences, Inc. entered into a warrant exercise inducement offer letters with certain holders of its Tranche B warrants, resulting in the exercise of the warrants and the issuance of new warrants. The company received approximately $19.4 million in gross proceeds from the exercise and sale of the warrants.